ARTICLE | Clinical News
ABX-1431: Phase Ia started
July 27, 2015 7:00 AM UTC
Abide began a double-blind, placebo-controlled, Belgian Phase Ia trial to evaluate single and multiple ascending doses of ABX-1431 in about 60 healthy volunteers. Abide said potential indications incl...